Becton Dickinson & Co. has agreed to settle the “vast majority” of the thousands of lawsuits claiming hernia patients were ...
Shares of Becton Dickinson & Co. BDX inched 0.36% higher to $238.22 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to ...
BD (Becton, Dickinson and Company) (BDX) announced an agreement to resolve the majority of its ongoing hernia litigation. The ...
Closure of plant announced last July with over 200 workers offered redundancy terms of five weeks’ pay capped at 104 weeks ...
Evercore ISI analyst Vijay Kumar raised the firm’s price target on Becton Dickinson (BDX) to $290 from $286 and keeps an ...
Becton Dickinson & Co. closed $32.25 short of its 52-week high ($269.52), which the company reached on October 10th.
Medical device manafacturer BD (Becton Dickinson) is to refer a dispute over severance packages at its Drogheda plant to the ...
MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...